Oral cyclosporine A treatment is feasible after myeloablative conditioning in allogeneic hematopoietic stem cell transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2710|40|3|358-361

ISSN： 0269-4727

Source： JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.40, Iss.3, 2015-06, pp. : 358-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retrospective Multicenter Study of Allogeneic Peripheral Blood Stem Cell Transplantation Followed by Reduced-Intensity Conditioning or Conventional Myeloablative Regimen

By  

Acta Haematologica, Vol. 113, Iss. 4, 2005-06 ,pp. : 220-227

Karger

Access to resources Recommend Favorite

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-02 ,pp. : 110-113

Karger

Access to resources Recommend Favorite

Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced‐intensity and myeloablative conditioning

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 2, 2015-02 ,pp. : 124-133

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide in hematopoietic stem cell transplantation for malignant infantile osteopetrosis

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 4, 2015-06 ,pp. : 422-427

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA‐identical sibling donor allogeneic hematopoietic cell transplantation

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 144-148

John Wiley & Sons Inc

Access to resources Recommend Favorite